Thomas E. Lyons

Novel Cam Mechanism for Core Sampling of Variable Density Materials

Ernest A. Franke, Paul T. Evans, Carl B. Allsup, 2008 .

Foot Pressure Abnormalities in the Diabetic Foot

Thomas E. Lyons, T. Lyons, A. Veves, 2012 .

Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers

Thomas E. Lyons, T. Dinh, T. Lyons, 2013, PloS one.

Early changes in the skin microcirculation and muscle metabolism of the diabetic foot

Thomas E. Lyons, R. Greenman, S. Panasyuk, 2005, The Lancet.

Diabetic Foot Complications: Diagnosis and Management

Thomas E. Lyons, J. Giurini, T. Lyons, 2005, The international journal of lower extremity wounds.

Management of the Diabetic Foot

Thomas E. Lyons, J. Giurini, T. Lyons, 1998 .

Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

Thomas E. Lyons, T. Lyons, T. Dinh, 2009, The Journal of clinical endocrinology and metabolism.

A retrospective assessment of partial calcanectomies and factors influencing postoperative course.

Thomas E. Lyons, J. Giurini, T. Lyons, 2007, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

Management of Diabetic Foot Complications

Thomas E. Lyons, T. Lyons, 2007 .

Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration

Thomas E. Lyons, J. Giurini, T. Lyons, 2012, Diabetes.

The Use of Medical Hyperspectral Technology to Evaluate Microcirculatory Changes in Diabetic Foot Ulcers and Predict Clinical Outcomes Received for publication 26 October 2006 and accepted in revised form 8 January 2007. Short title: Hyperspectral Technology in Diabetic Foot Ulceration

Thomas E. Lyons, R. Lew, K. Schomacker, 2007 .

Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.

Thomas E. Lyons, R. Kirsner, D. Armstrong, 2007, American journal of surgery.